Background In an ongoing outbreak of haemolytic uraemic syndrome and bloody diarrhoea caused by a virulent Escherichia coli strain O104:H4 in Germany (with some cases elsewhere in Europe and North America), 810 cases of the syndrome and 39 deaths have occurred since the beginning of May, 2011. We analysed virulence profi les and relevant phenotypes of outbreak isolates recovered in our laboratory.
Introduction
Starting in early May, 2011, an outbreak of haemolytic uraemic syndrome and bloody diarrhoea caused by Escherichia coli O104:H4 has spread throughout Germany. 1 As of June 20, 2011 , 810 cases of haemolytic uraemic syndrome, 2684 non-haemolytic uraemic syndrome cases, and 39 deaths have been reported by the Robert Koch Institute and European Centre for Disease Prevention and Control. The particular features of this outbreak are the predominant involvement of adult women 1 and common severe neurological complications, such as encephalopathy and epileptic seizures. Almost 100 infections with 39 cases of haemolytic uraemic syndrome caused by the outbreak strain have been reported in other European states including Austria, the Czech Republic, Denmark, France, Greece, Luxemburg, the Netherlands, Norway, Poland, Spain, Sweden (including one death), and the UK and in Canada and the USA-most non-German patients seem to be travellers returning from Germany. In the past 15 years, only a single E coli O104:H4 has been isolated from a patient with haemolytic uraemic syndrome in Germany 2 (HUSEC041, which is included in the collection of the National Consulting Laboratory for Haemolytic Uraemic Syndrome, University of Münster, Münster, Germany). A single additional case of the syndrome associated with E coli O104:H4 has also been reported from a woman in Korea. 3 To gain insight into the apparently augmented virulence of the outbreak strain, we analysed virulence profi les and relevant phenotypes of outbreak isolates recovered in our laboratory. We also determined phylogenetic relations of the isolates and their antimicrobial susceptibilities.
Methods

Stool samples and analysis
The fi rst stool sample from the suspected outbreak, originating from a patient with haemolytic uraemic syndrome, arrived at the National Consulting Laboratory for Haemolytic Uraemic Syndrome in Münster, Germany on May 23, 2011. By June 2, stools from 79 additional patients including 66 with haemolytic uraemic syndrome and 13 with bloody diarrhoea hospitalised in 22 hospitals in 17 diff erent German cities distributed in nine of 
Virulence analysis and antimicrobial susceptibility
Virulence profi les of the outbreak isolates were compared with those of HUSEC041 by use of a set of PCR analyses targeting a broad range of virulence and fi tness genes of Shiga-toxin producing E coli [5] [6] [7] [8] [9] [10] [11] [12] [13] that typically cause haemolytic uraemic syndrome, 14 such as those encoding toxins (stx 1 , stx 2 , EHEC-hlyA, cdt, subAB), serine proteases (espP), adhesins (eae, iha, lpfA O26 , lpfA O113 , lpfA O157-OI141 , lpfA O157-OI154 , saa, sfpA), iron acquisition system encoded on high pathogenicity island (marker genes irp2 and fyuA), and tellurite resistance (terD as a marker for the ter cluster). All isolates were PCR-tested for virulence loci typical for other intestinal pathogenic E coli including enteropathogenic (bfpA encoding structural subunit of bundle-forming pili), enterotoxigenic (elt and estI encoding heat-labile and heat-stable enterotoxin, respectively), enteroinvasive (ial, a marker for the virulence plasmid pInv), and enteroaggregative E coli (astA, sen, set1, and pic encoding toxins, aggA, aafA, agg3A, and agg4A encoding adhesins, aggR encoding transcription regulator, aap encoding dispersin, and aat as a marker for enteroaggregative E coli virulence plasmid). [15] [16] [17] [18] [19] [20] stx genes of four outbreak isolates from four diff erent cities were amplifi ed and Sanger sequenced; resulting sequences were analysed with the Ridom TraceEditPro Software (Ridom GmbH, Münster, Germany) and homologies were sought in GenBank.
The isolates were confi rmed as E coli (API 20 E, bioMérieux) and serotyped. 21 β-D-glucuronidase activity was assessed by use of nutrient agar with 4-methyl umbelliferyl-β-D-glucuronide (Becton Dickinson, Heidelberg, Germany). Production of entero haemor rhagic E coli haemolysin was sought on enterohaemolysin agar (Sifi n, Berlin, Germany), and production of α haemolysin on Columbia blood agar (Heipha, Heidelberg, Germany). Resistance to tellurite was determined by ability to grow on CT-SMAC. Shigatoxin production was identifi ed with the Vero cell cytotoxicity assay. 4 Adherence to human intestinal epithelial cells (HCT-8; ATCC CCL-244) was tested as described previously 22 by use of semiconfl uent monolayers incubated with the strains for 3 h in the presence of 0•5% D-mannose. Bacterial adherence patterns were examined with phase-contrast microscopy (AxioImagerA1; Zeiss, Jena, Germany) of washed, fi xed, and Giemsa-stained cells.
Antimicrobial susceptibility was determined by use of the Vitek 2 system version 05.02 (bioMérieux). Minimum inhibitory concentrations were interpreted in accordance with EUCAST 2010 guidelines. 
Genetic analysis
Multilocus sequence typing (MLST) was done by sequencing internal fragments of seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA, and recA). 24 The alleles and sequence type (ST) were assigned in accordance with the E coli MLST databases at the Environmental Research Institute, University College Cork, Ireland. In addition to MLST, all strains were subjected to partial gnd sequencing (627 bp internal gnd gene fragment, positions 397-1023 in strain W3110, GenBank accession number AP009048) in accordance to the protocol of Gilmour and colleagues 25 Three reference E coli O104 strains including HUSEC041 (O104:H4), HUSEC037 (O104:H21), and enteroaggregative E coli strain 55989 (O104:H4; GenBank accession number NC_011748) were included as controls. The partial gnd sequence enables prediction of the O-phase of E coli.
25
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Results
The fi rst outbreak strain (LB226692) was isolated in the German National Consulting Laboratory for Haemolytic Uraemic Syndrome in Münster on May 24, 2011. Molecular analysis of the isolate with PCR detected an stx 2 -positive, eae-negative Shiga-toxin-producing E coli, which was further characterised by sequence analysis of gnd, fl iC RFLP, and MLST as gnd O104 , fl iC H4 , and ST678. Moreover, the strain grew on CT-SMAC and possessed ter cluster encoding tellurite resistance. These characteristics of the isolate enabled us to develop the multiplex PCR targeting the typical molecular features of the strain (rfb O104 , fl iC H4 , stx 2 , and terD; fi gure 1), which we then used for identifi cation of the subsequent outbreak isolates. We proved specifi city of the multiplex PCR by showing that, among the 42 reference strains of the HUSEC collection and 100 additional Shiga-toxin-producing E coli of various serotypes as well as E coli from normal intestinal fl ora, only HUSEC041 gave amplicons for all the four loci targeted by the multiplex PCR. All 80 outbreak isolates possessed rfb O104 belonging to the O104 biosynthetic cluster and fl iC H4 belonging to the H4 antigen biosynthetic cluster, as determined by multiplex PCR (fi gure 1). gnd of all isolates was identical in the 627 bp sequenced fragment and it was identical to gnd of the two O104 reference strains in the HUSEC collection (HUSEC037 and HUSEC041) and of strain 55989 (GenBank accession number NC_011748), corroborating the O104 lipopolysaccharide phenotype. Presence of fl iC H4 was verifi ed using RFLP. All 80 isolates belonged to serotype O104:H4. All of them produced β-D-glucuronidase, fermented sorbitol and were tellurite resistant, and none produced enterohaemorrhagic E coli haemolysin or α haemolysin. All 80 isolates belonged to ST678, as does HUSEC041. This sequence type is unique to serotype O104:H4 among Shiga-toxin-producing E coli. On the basis of MLST, gnd sequence, and presence of fl iC H4 we concluded that the isolates were a single clone.
Each of the 80 outbreak isolates possessed virulence genes typical of Shiga-toxin-producing E coli, including stx 2 encoding the toxin, iha, lpf O26 , and lpf O113 encoding adhesins, and the high pathogenicity island originally identifi ed in Yersiniae and encoding an iron uptake system; 13 eae encoding adhesin intimin 15 was not present (table 2). The stx 2 sequence was identical in four randomly chosen outbreak isolates and was 99% homologous to stx 2 sequence of prototypic Shigatoxin-producing E coli O157:H7 strain EDL933 (GenBank AE005174), with one synonymous nucleotide change in each subunit gene (stxA 2 and stxB 2 ). Moreover, all isolates possessed typical molecular characteristics of enteroaggregative E coli, [15] [16] [17] [18] [19] [20] including the virulence plasmid (pAA), aggA encoding structural subunit of aggregative adherence fi mbriae I (AAF/I), aggR encoding the enteroaggregative E coli global regulator AggR, aap encoding dispersin, set1 encoding Shigella enterotoxin 1, and pic encoding an autotransporter serine protease (protein involved in intestinal colonisation). None of the isolates contained astA encoding enteroaggregative E coli heat-stable enterotoxin 1 (table 2). The absence of astA and the presence of the genes encoding AAF/I fi mbriae diff erentiate, among the 34 alleles investigated, the outbreak isolates from HUSEC041, which contains astA as well as agg3A encoding the structural subunit of AAF/III fi mbriae (table 2). These loci are also present in the reference enteroaggregative E coli strain 55989 (table 2) . The results of the PCR analyses are concordant with the draft genome data of an outbreak isolate LB226692 (NCBI accession number AFPS01000000) after in-silico analysis of primer binding sites and the resulting fragment length determination.
In addition to harbouring a mixture of virulence loci of two diff erent intestinal E coli pathotypes, all O104:H4 outbreak isolates also express the phenotypes that defi ne Shiga-toxin-producing E coli and enteroaggregative E coli, 15, 16 specifi cally production of Shiga-toxin 2 (Vero cell cytotoxicity titres 64-1024; median 256) and the aggregative (so-called stacked-brick) adherence pattern on intestinal epithelial cells (fi gure 2). The aggregative adherence phenotype (fi gure 2) combined with Shiga-toxin 2 production (Vero cell titre 64) are also displayed by HUSEC041. Virulence loci typically found in other intestinal pathogenic E coli including enteropathogenic, enteroinvasive, and enterotoxigenic E coli are absent from the O104:H4 outbreak isolates and from HUSEC041 (table 2) . All isolates have an ESBL phenotype-ie, they are resistant to all penicillins and cephalosporins and susceptible to carbapenems (ertapenem, imipenem, meropenem). This resistance pattern is typical for CTX-M-1 group β lactamases and corroborates the already reported fi ndings of the CTX-M-15 genotype. 26 Furthermore, all strains are resistant to co-trimoxazole (trimethoprim-sulfamethoxazole) and susceptible to fl uoroquinolones (ciprofl oxacin) and aminoglycosides (gentamicin, tobramycin). HUSEC041 did not have the ESBL phenotype.
Discussion
The genotypes, phenotypes, and phylogeny of the 80 outbreak isolates demonstrate that the E coli O104:H4 outbreak strain is a clone that combines virulence potentials of two diff erent pathogens: Shiga-toxinproducing E coli and enteroaggregative E coli (panel). HUSEC041, isolated in 2001 from a child with haemolytic uraemic syndrome in Germany, also had this virulence combination.
Isolation of this rare E coli O104:H4 serotype in many samples and in a short time confi rms that this is the outbreak strain; however, we do not have access to the entire strain collection from this outbreak because no single laboratory has statutory authority for the analysis or possession of these isolates. Because of the rapidly increasing number of infected people and the severity of the disease, identifi cation and profi ling of the outbreak strain as expeditiously as possible was essential. In this race against time, sequence analysis of gnd, identifi cation of ST678 (which is unique to serotype O104:H4 among Shiga-toxin-producing E coli, until now reported only in the HUSEC041 reference strain from 2001), and identifi cation of fl iC H4 together with the presence of stx 2 were the crucial points in determining the novelty of the strain just 2 days after the fi rst stool arrived. This is of particular importance because in addition to E coli O104:H4, there are also other Shiga-toxin-producing E coli of serogroup O104, but these possess diff erent H antigen. 27 The most common is Shigatoxin-producing E coli O104:H21 represented in our HUSEC collection by HUSEC037. An O104:H21 strain, which is similar to the E coli O104:H4 outbreak strain, also eae-negative, caused an outbreak of bloody diarrhoea associated with consumption of raw milk in Montana, USA, in 1994. 28 Taken together, the availability of the HUSEC collection including representative, well-characterised (genotypically and phenotypically) Shiga-toxin-producing E coli strains of all serotypes associated with haemolytic uraemic syndrome in Germany during the past 15 years and of gnd sequencing, fl iC-RFLP and MLST enabled us in a very short time to identify the outbreak isolates as E coli O104:H4. These data and the rapidity with which the outbreak strain has been characterised show the value of standing collections of well characterised pathogens with known provenance, which was the purpose of the HUSEC collection. Moreover, implementation of well established, reproducible, and independent techniques, such as PCR and phenotypic tests available in our laboratory 4, 5, 6, 8, 12, 22 enabled further rapid characterisation of the outbreak strain. The outbreak strain, which is a sorbitol fermenter, would have been missed by standard diagnostic procedures focused on the O157:H7 strain and using SMAC to identify this organism on the basis of its lack of sorbitol fermentation. However, the ESBL resistance of the outbreak strain aided its recovery from patients' stool samples by use of culture on ESBL agar. This feature might be used to seek reservoirs of this strain and to recover the organism from suspected vehicles of transmission.
The reason for the apparently augmented virulence potential of the outbreak O104:H4 strain, as indicated by the high amount of haemolytic uraemic syndrome cases and 39 deaths, is unknown, but our data suggest some possibilities. The enhanced adherence of this strain to intestinal epithelial cells (fi gure 2) might facilitate systemic absorption of Shiga toxin and could explain the high frequency of progression to haemolytic uraemic syndrome. Antibiotic resistance might also play a part if β-lactam drugs used to treat the infection suppressed competing microbiota. When the outbreak strain acquired a plasmid encoding CTX-M-15, which is absent in the original HUSECO41 isolate from 2001, is unknown. This plasmid has been identifi ed in several diff erent genera in the Enterobacteriaceae. 29 Our data do not permit us to state if the Shiga-toxin-producing and enteroaggregative traits in E coli O104:H4 combined recently, or if this pathogen is coming to light now because of conditions suitable for its spread. An E coli O111 strain that expressed Shiga toxin and displayed an aggregative adherence on epithelial cells 30 caused an outbreak of haemolytic uraemic syndrome in France 
Search strategy
We searched the PubMed database for papers published in English between Jan 1, 1990, and June 14, 2011, with the search terms "O104", "O104:H4", "HUS" (haemolytic uraemic syndrome), "enteroaggregative", or "enterohaemorrhagic". No articles provided a comprehensive characterisation of the enterohaemorrhagic Escherichia coli O104:H4 causing a large outbreak in Germany.
Interpretation E coli O104:H4, which has characteristics and genetic loci found in Shiga-toxin-producing E coli and enteroaggregative E coli, is unprecedented among enteric pathogens in its virulence. This isolate belongs to the rare sequence type 678 and produces Shiga toxin 2 and aggregative adherence to intestinal epithelial cells. This pathogen, and this outbreak, will have profound implications for disease detection, reporting, food safety, and our understanding of microbial pathogenesis.
15 years ago, 31 but the number of cases (ten) was lower than in the ongoing German outbreak (810 as of June 20) . Diff erences in virulence potentials of the O111 and O104 outbreak strains, modes of transmission, the infectious dose present in the vehicle of infection (recently, sprouts have been identifi ed as a source of the German outbreak), 32 and general susceptibilities of the human hosts to these two strains might play a part. Although we lack an explanation for increased virulence, this outbreak tragically shows that blended virulence profi les in enteric pathogens introduced into susceptible populations can have serious consequences for infected people.
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